Synapse - Phase II single-arm, single-institution trial of neoadjuvant gemcitabine and oxaliplatin treatment (NT) in patients (pts) with resectable pancreas adenocarcinoma (PC)

Phase II single-arm, single-institution trial of neoadjuvant gemcitabine and oxaliplatin treatment (NT) in patients (pts) with resectable pancreas adenocarcinoma (PC) Meeting Abstract

Authors:	O'Reilly, E. M.; Jarnagin, W. R.; Brennan, M. F.; Winston, C.; Tang, L. H.; Capanu, M.; Schattner, M.; Chen, L. Y.; DeMatteo, R. P.; DiMaio, C. J.; D'Angelica, M. I.; Kurtz, R. C.; Klimstra, D. S.; Lowery, M. A.; Coit, D. G.; Reidy, D. L.; Allen, P. J.
Abstract Title:	Phase II single-arm, single-institution trial of neoadjuvant gemcitabine and oxaliplatin treatment (NT) in patients (pts) with resectable pancreas adenocarcinoma (PC)
Meeting Title:	47th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title:	Journal of Clinical Oncology
Volume:	29
Issue:	15 Suppl.
Meeting Dates:	2011 Jun 3-7
Meeting Location:	Chicago, IL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2011-05-20
Language:	English
ACCESSION:	WOS:000208880300475
DOI:	10.1200/jco.2011.29.15_suppl.4065
PROVIDER:	wos
Notes:	Meeting Abstract: 4065 -- Source: Wos